ELI LILLY & Co·4

Feb 14, 4:19 PM ET

Norton Johna 4

4 · ELI LILLY & Co · Filed Feb 14, 2024

Insider Transaction Report

Form 4
Period: 2024-02-12
Norton Johna
Senior VP, Global Quality
Transactions
  • Award

    Common Stock

    2024-02-12$737.26/sh+1,668$1,229,75032,484 total
  • Award

    Restricted Stock Unit

    2024-02-12+1,3081,308 total
    From: 2025-02-01Exp: 2025-02-01Common Stock (1,308 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    402
  • Common Stock

    (indirect: By 401(k))
    1,769
  • Common Stock

    (indirect: by partner)
    128
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wk-form4_1707945531.xmlPrimary

    FORM 4